Cargando…
The Chinese medicine formula HB01 reduces choroidal neovascularization by regulating the expression of vascular endothelial growth factor
BACKGROUND: Choroidal neovascularization (CNV) remains the leading cause of newly acquired blindness in the developed world. Currently anti-vascular endothelial growth factor (VEGF) therapies are broadly used to treat neovascular ocular disorders. Here we demonstrate the effect of a traditional Chin...
Autores principales: | Jin, Ming, Zhang, Youhua, Pan, Lin, Dou, Renhui, Nussenblatt, Robert B, Wei, Lai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479009/ https://www.ncbi.nlm.nih.gov/pubmed/22676316 http://dx.doi.org/10.1186/1479-5876-10-118 |
Ejemplares similares
-
Lycopene inhibits endothelial‐to‐mesenchymal transition of choroidal vascular endothelial cells in laser‐induced mouse choroidal neovascularization
por: Li, Lele, et al.
Publicado: (2023) -
Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
por: Ruparelia, Sunil, et al.
Publicado: (2021) -
Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
por: Yeo, Natalie Jia Ying, et al.
Publicado: (2019) -
Anti-vascular endothelial growth factors for choroidal neovascularization secondary to choroidal osteoma: Long-term results
por: Lekha, T., et al.
Publicado: (2015) -
Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)